Login
$PMN
$9.68 +$1.62 (20.1%) Live

Company Executives

$PMN Management Team

Mr. Eugene Williams

Chairman of the Board

Age 65
Compensation $84.97K CAD
Sex Male

Mr. Neil Warma

President

Chief Executive Officer

Director

Age 62
Compensation $2.344M CAD
Sex Male

Dr. Neil Cashman

Chief Scientific Officer

Director

Age 73
Compensation $515.9K CAD
Sex Male

Mr. Larry Altstiel

Chief Medical Officer

Age 75
Compensation -
Sex Male

Dr. Johanne Kaplan

Chief Development Officer

Age 65
Compensation $664.6K CAD
Sex Female

Mr. Daniel Geffken

Chief Financial Officer

Age 68
Compensation $180.1K CAD
Sex Male
Directors
8
serving now
Independent
4 of 4
stated in the proxy; 4 not stated
Average tenure
7.9 years
from year joined
CEO also chairs the board
No
Eugene Williams
Director Age On board Independent Committees Other public boards Pay Source
Neil Warma
63 2021
5 years
Not stated None stated None stated Paid as CEO
Neil Cashman
74 2010
16 years
Not stated None stated None stated Not stated
Eugene Williams
66 2015
11 years
Not stated None stated None stated Not stated
Maggie Shafmaster
67 2021
5 years
Independent None stated None stated Not stated
William Wyman
88 2014
12 years
Independent None stated None stated Not stated
Josh Mandel-Brehm
43 2021
5 years
Independent None stated None stated Not stated
Slanix Alex
36 2025
1 year
Independent None stated None stated Not stated
Patrick Kirwin Leaving at the meeting
Not stated Not stated Not stated None stated None stated Not stated

Each director opens the passage of the proxy that names them. "Not stated" means the proxy does not say; it never means "no". Pay is the proxy's Director Compensation table; the CEO is paid as an executive.

16 disclosed in the proxy filed Apr 9, 2026
Neil Cashman
Chief Scientific Officer
$428,860 and $605,645
2025 and 2024

Collaborative research agreement with UBC and Vancouver Coastal Health Authority; Company made cash payments under it

With University of British Columbia Open in proxy
Eugene Williams
consultant to the Company under the Williams Consulting Agreement
$168,750 and $225,000
2025 and 2024

Strategic services consulting agreement; cash consulting fees paid to Mr. Williams

Entities Affiliated with Janus Henderson
$14,999,983
January 2026

Private offering purchase of Common Shares, pre-funded warrants and Warrants

Entities Affiliated with Ally Bridge Group
$8,499,988
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Ally Bridge Group
$5,469,468
July 2025

Private offering warrant exercise and acquisition of warrants

Entities Affiliated with Deep Track
$9,000,004
January 2026

Private offering purchase of Common Shares and warrants

Wellington Biomedical Innovation Master Investors (Cayman) II L.P.
$7,499,991
January 2026

Private offering purchase of Common Shares and warrants

Trails Edge Biotechnology Master Fund, LP
$5,999,999
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Great Point
$4,000,000
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Sphera
$3,500,002
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Jeremy Sclar
$2,499,997
January 2026

Private offering purchase of Common Shares and warrants

Entities Affiliated with Jeremy Sclar
$2,336,713
July 2025

Private offering warrant exercise and acquisition of warrants

Woodline Master Fund LP
$4,000,000
January 2026

Private offering purchase of Common Shares and warrants

Shaf QIC, LLC
$1,399,992
January 2026

Private offering purchase of Common Shares and warrants

Shaf QIC, LLC
$784,884
July 2025

Private offering warrant exercise and acquisition of warrants

Squadron Master Fund LP
$3,500,002
January 2026

Private offering purchase of Common Shares and warrants

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support